Myocyte enhancer factor 2D (MEF2D) is involved in many aspects of cancer progression, including cell proliferation, invasion, and migration. However, little is known about the role of MEF2D in tumor angiogenesis. Using clinical specimens, colorectal cancer (CRC) cell lines and a mouse model in the present study, we found that MEF2D expression was positively correlated with CD31-positive microvascular density in CRC tissues. MEF2D promoted tumor angiogenesis in vitro and in vivo and induced the expression of proangiogenic cytokines in CRC cells.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2paqxw9
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
by Sofie V. Nielsen, Amelie Stein, Alexander B. Dinitzen, Elena Papaleo, Michael H. Tatham, Esben G. Poulsen, Maher M. Kassem, Lene J. Rasm...
-
Abstract RNA degradation is a major problem in tissue banking. We explored the effect of thawing flash-frozen biospecimens on the quality a...
-
Abstract Purpose In targeted radionuclide therapy (TRT), a prior knowledge of the absorbed dose biodistribution is essential for pre-the...
-
From Italian : Pedro and Domenico jump, but Oreste thinks about it a bit... and finds another solution. #donkey #problemsolving Posted a...
-
Correction to: Ecological risk assessment of metals in sediments and selective plants of Uchalli Wetland Complex (UWC)—a Ramsar site The cor...
-
In metabolomics, thousands of substances can be detected in a single assay. This capacity motivates the development of metabolomics testing,...
-
http://ift.tt/2ukCAsE
-
An Essay Writing Service You Can Trust. By choosing you guarantee that you’ll get a high quality, unique and 100% plagiarism-free essay deli...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου